{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:09:00Z","timestamp":1789096140772,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,10]]},"DOI":"10.7759\/cureus.116074","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:39:07Z","timestamp":1789094347000},"source":"Crossref","is-referenced-by-count":0,"title":["A Structured, Auditable Taxonomy for Pharmacist-Identifiable Medication-Related Risk Signals in Routine Admission Data: A Retrospective Medication Safety Audit in a High-Risk Inpatient Cohort"],"prefix":"10.7759","author":[{"given":"Hidenori","family":"Sagara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momoka","family":"Yamane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhide","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Inamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisako","family":"Teshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12364","article-title":"Pharmacy-led medication reconciliation programmes at hospital transitions: a systematic review and meta-analysis","volume":"41","author":"Mekonnen AB","year":"2016","unstructured":"Mekonnen AB, McLachlan AJ, Brien JA. Pharmacy-led medication reconciliation programmes at hospital transitions: a systematic review and meta-analysis. J Clin Pharm Ther. 2016, 41:128-44. 10.1111\/jcpt.12364","journal-title":"J Clin Pharm Ther"},{"key":"ref2","article-title":"","author":"Royal Pharmaceutical Society","year":"2013","unstructured":"Royal Pharmaceutical Society. Medicines Optimisation: Helping Patients to Make the Most of Medicines. Royal Pharmaceutical Society, London; 2013. https:\/\/www.rcpharm.org\/wp-content\/uploads\/2026\/05\/helping-patients-make-the-most-of-their-medicines.pdf."},{"key":"ref3","article-title":"Medication Without Harm: WHO Global Patient Safety Challenge","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. Medication Without Harm: WHO Global Patient Safety Challenge. World Health Organization, Geneva; 2017."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010791.pub2","article-title":"Impact of medication reconciliation for improving transitions of care","volume":"8","author":"Redmond P","year":"2018","unstructured":"Redmond P, Grimes TC, McDonnell R, Boland F, Hughes C, Fahey T. Impact of medication reconciliation for improving transitions of care. Cochrane Database Syst Rev. 2018, 8:CD010791. 10.1002\/14651858.CD010791.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2019.10.011","article-title":"Impact of medication reconciliation on health outcomes: an overview of systematic reviews","volume":"16","author":"Guisado-Gil AB","year":"2020","unstructured":"Guisado-Gil AB, Mej\u00edas-Trueba M, Alfaro-Lara ER, S\u00e1nchez-Hidalgo M, Ram\u00edrez-Duque N, Santos-Rubio MD. Impact of medication reconciliation on health outcomes: an overview of systematic reviews. Res Social Adm Pharm. 2020, 16:995-1002. 10.1016\/j.sapharm.2019.10.011","journal-title":"Res Social Adm Pharm"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s40780-020-00174-8","article-title":"Association of the ward pharmacy service with active implementation of therapeutic drug monitoring for vancomycin and teicoplanin-an epidemiological surveillance study using Japanese large health insurance claims database","volume":"6","author":"Imai S","year":"2020","unstructured":"Imai S, Momo K, Kashiwagi H, Miyai T, Sugawara M, Takekuma Y. Association of the ward pharmacy service with active implementation of therapeutic drug monitoring for vancomycin and teicoplanin-an epidemiological surveillance study using Japanese large health insurance claims database. J Pharm Health Care Sci. 2020, 6:18. 10.1186\/s40780-020-00174-8","journal-title":"J Pharm Health Care Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.4.424","article-title":"Unintended medication discrepancies at the time of hospital admission","volume":"165","author":"Cornish PL","year":"2005","unstructured":"Cornish PL, Knowles SR, Marchesano R, Tam V, Shadowitz S, Juurlink DN, Etchells EE. Unintended medication discrepancies at the time of hospital admission. Arch Intern Med. 2005, 165:424-9. 10.1001\/archinte.165.4.424","journal-title":"Arch Intern Med"},{"key":"ref8","article-title":"Global Patient Safety Action Plan 2021-2030: Towards Eliminating Avoidable Harm in Health Care","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. Global Patient Safety Action Plan 2021-2030: Towards Eliminating Avoidable Harm in Health Care. World Health Organization, Geneva; 2021."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/47.3.533","article-title":"Opportunities and responsibilities in pharmaceutical care","volume":"47","author":"Hepler CD","year":"1990","unstructured":"Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990, 47:533-43. 10.1093\/ajhp\/47.3.533","journal-title":"Am J Hosp Pharm"},{"key":"ref10","article-title":"","author":"Pharmaceutical Care Network Europe","year":"2020","unstructured":"Pharmaceutical Care Network Europe. PCNE Classification for Drug-Related Problems V9.1. Pharmaceutical Care Network Europe, Zuidlaren, the Netherlands; 2020. https:\/\/www.pcne.org\/upload\/files\/417_PCNE_classification_V9-1_final.pdf."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.sapharm.2019.04.005","article-title":"The medication discrepancy taxonomy (MedTax): the development and validation of a classification system for medication discrepancies identified through medication reconciliation","volume":"16","author":"Almanasreh E","year":"2020","unstructured":"Almanasreh E, Moles R, Chen TF. The medication discrepancy taxonomy (MedTax): the development and validation of a classification system for medication discrepancies identified through medication reconciliation. Res Social Adm Pharm. 2020, 16:142-8. 10.1016\/j.sapharm.2019.04.005","journal-title":"Res Social Adm Pharm"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/1941874415588319","article-title":"In-hospital ischemic stroke","volume":"5","author":"Cumbler E","year":"2015","unstructured":"Cumbler E. In-hospital ischemic stroke. Neurohospitalist. 2015, 5:173-81. 10.1177\/1941874415588319","journal-title":"Neurohospitalist"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2020.3362","article-title":"Trends in reperfusion therapy for in-hospital ischemic stroke in the endovascular therapy era","volume":"77","author":"Akbik F","year":"2020","unstructured":"Akbik F, Xu H, Xian Y, et al.. Trends in reperfusion therapy for in-hospital ischemic stroke in the endovascular therapy era. JAMA Neurol. 2020, 77:1486-95. 10.1001\/jamaneurol.2020.3362","journal-title":"JAMA Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm E","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007, 370:1453-7. 10.1016\/S0140-6736(07)61602-X","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/nur.20147","article-title":"The content validity index: are you sure you know what's being reported? Critique and recommendations","volume":"29","author":"Polit DF","year":"2006","unstructured":"Polit DF, Beck CT. The content validity index: are you sure you know what's being reported? Critique and recommendations. Res Nurs Health. 2006, 29:489-97. 10.1002\/nur.20147","journal-title":"Res Nurs Health"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-019-0284-9","article-title":"The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)","volume":"42","author":"Umemura S","year":"2019","unstructured":"Umemura S, Arima H, Arima S, et al.. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019, 42:1235-481. 10.1038\/s41440-019-0284-9","journal-title":"Hypertens Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s13340-020-00439-5","article-title":"Japanese Clinical Practice Guideline for Diabetes 2019","volume":"11","author":"Araki E","year":"2020","unstructured":"Araki E, Goto A, Kondo T, et al.. Japanese Clinical Practice Guideline for Diabetes 2019. Diabetol Int. 2020, 11:165-223. 10.1007\/s13340-020-00439-5","journal-title":"Diabetol Int"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh ML","year":"2012","unstructured":"McHugh ML. Interrater reliability: the kappa statistic. Biochem Med (Zagreb). 2012, 22:276-82. 10.11613\/BM.2012.031","journal-title":"Biochem Med (Zagreb)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage BF","year":"2001","unstructured":"Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001, 285:2864-70. 10.1001\/jama.285.22.2864","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.19271","article-title":"Interventions to improve medication adherence: a review","volume":"320","author":"Kini V","year":"2018","unstructured":"Kini V, Ho PM. Interventions to improve medication adherence: a review. JAMA. 2018, 320:2461-73. 10.1001\/jama.2018.19271","journal-title":"JAMA"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2013.02.001","article-title":"Adherence to cardiovascular medications: lessons learned and future directions","volume":"55","author":"Kronish IM","year":"2013","unstructured":"Kronish IM, Ye S. Adherence to cardiovascular medications: lessons learned and future directions. Prog Cardiovasc Dis. 2013, 55:590-600. 10.1016\/j.pcad.2013.02.001","journal-title":"Prog Cardiovasc Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2017.03.008","article-title":"Medication adherence outcomes of 771 intervention trials: systematic review and meta-analysis","volume":"99","author":"Conn VS","year":"2017","unstructured":"Conn VS, Ruppar TM. Medication adherence outcomes of 771 intervention trials: systematic review and meta-analysis. Prev Med. 2017, 99:269-76. 10.1016\/j.ypmed.2017.03.008","journal-title":"Prev Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31822f0423","article-title":"Secondary preventive medication persistence and adherence 1 year after stroke","volume":"77","author":"Bushnell CD","year":"2011","unstructured":"Bushnell CD, Olson DM, Zhao X, et al.. Secondary preventive medication persistence and adherence 1 year after stroke. Neurology. 2011, 77:1182-90. 10.1212\/WNL.0b013e31822f0423","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.62.8.1217","article-title":"Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke","volume":"62","author":"Maulaz AB","year":"2005","unstructured":"Maulaz AB, Bezerra DC, Michel P, Bogousslavsky J. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol. 2005, 62:1217-20. 10.1001\/archneur.62.8.1217","journal-title":"Arch Neurol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.119.005969","article-title":"Real-world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"13","author":"Ozaki AF","year":"2020","unstructured":"Ozaki AF, Choi AS, Le QT, Ko DT, Han JK, Park SS, Jackevicius CA. Real-world adherence and persistence to direct oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2020, 13:e005969. 10.1161\/CIRCOUTCOMES.119.005969","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"ref26","article-title":"Adherence to Long-Term Therapies: Evidence for Action","author":"World Health Organization","year":"2003","unstructured":"World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. World Health Organization, Geneva; 2003."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/528876-a-structured-auditable-taxonomy-for-pharmacist-identifiable-medication-related-risk-signals-in-routine-admission-data-a-retrospective-medication-safety-audit-in-a-high-risk-inpatient-cohort","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:39:08Z","timestamp":1789094348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/528876-a-structured-auditable-taxonomy-for-pharmacist-identifiable-medication-related-risk-signals-in-routine-admission-data-a-retrospective-medication-safety-audit-in-a-high-risk-inpatient-cohort"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.116074","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,10]]}}}